Table 3.
Body composition of study subjects before (0 W) and after (12 W) NMN intervention
| Unit | Placebo group | NMN group | ANCOVA | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Body weight | kg | 0 W | 59.6 | ± | 11.7 | 58.7 | ± | 10.3 | |
| 12 W | 59.4 | ± | 11.9 | 58.2 | ± | 10.6 | 0.254 | ||
| Body fat mass | kg | 0 W | 15.7 | ± | 6.1 | 15.7 | ± | 4.8 | |
| 12 W | 17.1 | ± | 6.4 | 16.6 | ± | 5.0 | 0.068 | ||
| Skeletal muscle mass | kg | 0 W | 23.7 | ± | 5.1 | 23.2 | ± | 4.8 | |
| 12 W | 22.7 | ± | 4.9 | 22.3 | ± | 4.7 | 0.703 | ||
| Body mass index | kg/m2 | 0 W | 22.6 | ± | 3.6 | 22.4 | ± | 2.6 | |
| 12 W | 22.6 | ± | 3.7 | 22.2 | ± | 2.7 | 0.262 | ||
| Skeletal muscle mass index | kg/m2 | 0 W | 6.9 | ± | 1.0 | 6.7 | ± | 1.0 | |
| 12 W | 6.5 | ± | 1.0 | 6.4 | ± | 1.1 | 0.701 | ||
Means ± standard deviation are shown
Efficacy analysis population: N = 59 (placebo group N = 29, NMN group N = 30)